INS and polycystic ovary syndrome: Network pharmacology and molecular docking techniques were applied to identify potential drug-disease targets and active constituents.<h4>Results</h4>QGW significantly restored regular estrous cycles, reduced testosterone, fasting insulin, and HOMA-IR levels, and improved ovarian morphology in PCOS-IR rats.